학술논문

Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; JUN 2023, 11 6, pe006654 11p.
Subject
Language
English
ISSN
20511426